solution injectable en seringue préremplie

DRUG10 trials

Sponsors

Centre Hospitalier Universitaire De Saint Etienne, Institut Gustave Roussy, Centre Hospitalier Universitaire De Nantes, University College Dublin, Centre Hospitalier Universitaire D'Angers

Conditions

Adult subject (18 years of age older) with low or intermediate-1 IPSS risk MDS with transfusions independent anemiaCrohn’s DiseaseLow risk myelodysplastic syndrom without RS having failed or being ineligible to Erythroid Stimulating AgentLower limb trauma requiring immobilisationMultiple SclerosisPost-operative pain after surgeryThromboprophylaxis in good and intermediate prognosis advanced germ cell tumorsTraumatic Injury

Phase 1

COMBOLA Trial: A randomized phase I/ II multicenter study evaluating combination of luspatercept in LR-MDS without RS having failed or being ineligible to ESA

RecruitingCTIS2024-515354-24-00

Groupe Francophone Des MyelodysplasiesLow risk myelodysplastic syndrom without RS having failed or being ineligible to Erythroid Stimulating Agent

Start: 2022-05-18Target: 160Updated: 2025-12-23

Phase 2

Improving outcome in subarachnoid hemorrhage with nadroparin

Not yet recruitingCTIS2024-511679-14-00

Amsterdam UMC Stichtingsubarachnoid hemorrhage

Target: 100Updated: 2024-08-08

Phase 3

Best Antithrombotic Therapy in patients with acute Venous ThromboEmbolism while taking antiplatelets: the BAT-VTE

RecruitingCTIS2022-500974-33-00

Centre Hospitalier Universitaire De Saint Etienneacute venous thromboembolism event

Start: 2023-08-12Target: 1400Updated: 2025-04-25

Thromboprophylaxis in good and intermediate prognosis advanced germ cell tumors (GIG-T)

RecruitingCTIS2022-502426-41-00

Institut Gustave RoussyThromboprophylaxis in good and intermediate prognosis advanced germ cell tumors

Start: 2023-10-17Target: 387Updated: 2026-01-13

RIVACAST - RIVAroxaban versus low-molecular weight heparin in patients with lower limb trauma requiring brace or CASTing

RecruitingCTIS2023-509905-62-00

Centre Hospitalier Universitaire D'AngersLower limb trauma requiring immobilisation

Start: 2024-07-19Target: 1424Updated: 2025-10-06

A randomised, double-blind, placebo-controlled trial of erythropoietin alfa versus placebo in mechanically ventilated critically ill patients following traumatic injury

RecruitingCTIS2023-506081-31-00

University College DublinTraumatic Injury

Start: 2022-03-29Target: 1243Updated: 2025-08-12

Comparison of azathioprine to methotrexate in combination therapy with adalimumab in Crohn’s Disease: an open-label randomized controlled trial

Not yet recruitingCTIS2024-514633-38-00

Centre Hospitalier Universitaire Amiens PicardieCrohn’s Disease

Target: 166Updated: 2025-10-15

DISEASE MODIFYING THERAPIES WITHDRAWAL IN INACTIVE RELAPSING-REMITTING MULTIPLE SCLEROSIS PATIENTS AGED 55 AND OVER: A MULTICENTRIC, RANDOMIZED, CONTROLLED, OPEN-LABEL CLINICAL TRIAL - TWINS

RecruitingCTIS2024-513475-41-00

Les Hopitaux Universitaires De StrasbourgMultiple Sclerosis

Start: 2025-02-03Target: 200Updated: 2024-11-08

GFM-EPO-PRETAR: A randomized trial testing early versus late onset of EPO alfa treatment in lower risk MDS with non RBC transfusion dependent anemia and without del 5q

CompletedCTIS2024-515356-21-00

Groupe Francophone Des MyelodysplasiesAdult subject (18 years of age older) with low or intermediate-1 IPSS risk MDS with transfusions independent anemia

Start: 2018-04-17End: 2024-10-29Target: 124Updated: 2024-09-24

Phase 4

Avoid With locoregional Analgesia Persistant Postoperative Pain After Surgery In Children

RecruitingCTIS2023-503499-25-00

Centre Hospitalier Universitaire De NantesPost-operative pain after surgery

Start: 2024-06-06Target: 222Updated: 2024-10-11